Received: 15 June 2021
Accepted: 29 September 2021
First Online: 6 October 2021
: This clinical trial was approved by the Institutional Review Board of Dow University of Health Sciences (Ref: IRB-1351/DUHS/Approval/2019/184) and was registered under the protocol ID NCT04249336 (ExternalRef removed) on January 30, 2020, in accordance with the CONSORT statement of the updated guidelines for reporting randomised clinical trials. Written consent was obtained from all participants to participate in the six-week clinical trial.
: Not applicable.
: The authors declare that they have no competing interests (financial and non-financial) related to the article.